Investor Summary
Fund Strategy
FUND PERFORMANCE AS OF 31st March 2026
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 9.23% | 8.18% | 8.18% |
| ANNUALIZED SINCE INCEPTION | QUARTERLY | YTD |
|---|---|---|
| 9.23% | 8.18% | 8.18% |
The Brandes Small Cap Value Fund delivered strong performance in Q1 2026, returning 8.18% and significantly outperforming both the Russell 2000 Index (0.89%) and Russell 2000 Value Index (4.96%). Industrials drove performance, led by machinery companies Kennametal and Graham Corporation, which benefited from tungsten price increases and strong earnings respectively. Consumer staples holdings Ingles Markets and Edgewell Personal Care also contributed positively through operational recovery and balance sheet strengthening. Technology holdings faced headwinds from AI disruption concerns, with IT services companies and software businesses declining as investors reassessed the impact of generative AI on traditional business models. The fund actively rebalanced during the quarter, reducing industrials exposure while substantially increasing consumer staples allocation through new positions in Molson Coors, Ingredion, and Lamb Weston. Management maintains an optimistic outlook on value stocks and believes the fund remains well-positioned for long-term outperformance through its focus on companies with strong fundamentals and attractive valuations.
The Brandes Small Cap Value Fund focuses on undervalued small-cap companies with strong balance sheets, compelling growth prospects, and durable free-cash-flow generation, believing these characteristics provide attractive long-term risk/reward potential in the small-cap value space.
Management remains optimistic about the potential of value stocks in general and believes the Brandes Small Cap Value Fund remains well positioned from a long-term risk/reward perspective. They view the fund as an attractive complement to other small-cap offerings due to its focus on companies with strong balance sheets, compelling growth prospects, and durable free-cash-flow generation.
| Date | Letter | Tickers | Keywords | Pitches | Quick Takes |
|---|---|---|---|---|---|
| Apr 21 2026 | 2026 Q1 | DOX, EPC, GLOB, KMT, LNSR, MHK, NICE, OTEX, PKE | AI, Consumer Staples, industrials, Outperformance, small cap, technology, value |
MHK NICE MHK NICE |
Brandes Small Cap Value Fund outperformed significantly in Q1 2026 with 8.18% returns versus 0.89% for Russell 2000. Industrials and consumer staples drove performance while technology holdings faced AI disruption concerns. Management actively rebalanced the portfolio and remains optimistic about value opportunities in small-cap stocks with strong fundamentals. |
| Jan 23 2026 | 2025 Q4 | ALKS, AOBC, ARLO, AVDL, CENT, DIIBF, ELAN, EPC, GHM, GIL, GRFS, HURC, HXL, IMKTA, INVX, KMT, MOG.A, NTGR, ORN, PKE, PZZA, RGP, SEE, UTMD | healthcare, industrials, Outperformance, positioning, small caps, value | CENT | Brandes Small Cap Value Fund outperformed with 5.88% quarterly returns driven by industrials holdings including Kennametal, Graham Corporation, Moog, and Hexcel. The fund sold Avadel after a bidding war reached intrinsic value and added Central Garden & Pet as an attractive value opportunity. Management maintains optimism on value stocks with differentiated positioning versus small-cap benchmarks. |
| Oct 21 2025 | 2025 Q3 | AOUT, ARLO, AVDL, ELAN, EPC, GIL.TO, GLOB, HBI, HURC, HXL, IEX, KMT, MOG.A, ORION, PAHC, PBH, PINC, PKE, SON, UNF | healthcare, industrials, positioning, small caps, technology, underperformance, value |
GLOB PBH GLOB PBH |
Brandes Small Cap Value Fund underperformed in Q3 but outperformed year-to-date, driven by healthcare winners like Elanco and Avadel. The fund harvested gains from Premier and Phibro while adding defensive consumer healthcare play Prestige and beaten-down IT services company Globant. Manager remains optimistic on small-cap value opportunities despite near-term headwinds. |
| Jul 22 2025 | 2025 Q2 | AOUT, ARLO, AVDL, ELAN, EPC, GIL.TO, GLOB, HBI, HURC, HXL, IEX, KMT, MOG.A, ORION, PAHC, PBH, PINC, PKE, SON, UNF | healthcare, industrials, positioning, small caps, underperformance, value |
PBH GLOB |
Brandes Small Cap Value Fund underperformed in Q3 despite strong healthcare contributions from animal health names. The fund capitalized on weakness to add Prestige Consumer Healthcare and deeply discounted IT services company Globant. Management maintains conviction in their value approach, emphasizing the fund's attractive long-term positioning with lower valuations than broader small-cap markets. |
| Mar 31 2025 | 2025 Q1 | AOBC, ARLO, BZU, CFP, ELAN, ERJ, EWG, FSTR, GHM, HBI, HXL, IMKTA, KMT, MOG.A, ORION, PBH, PKE, PZZA, SR | consumer discretionary, healthcare, industrials, small caps, value | PZZA | Brandes Small Cap Value Fund outperformed the Russell 2000 despite a 6.48% decline in Q1 2025. Buyout announcements drove gains in LENSAR and SolarWinds while industrial and consumer discretionary holdings faced earnings headwinds. The fund initiated positions in Papa John's and Canfor, maintaining its value-focused approach targeting companies with strong fundamentals trading below intrinsic value. |
| Dec 31 2024 | 2024 Q4 | AOUT, ARLO, BSCAX, BSCMX, BSCRX, CAE, DII, ELAN, EPC, ERJ, EXE, FSTR, GHM, HBI, HXL, IMKTA, INVX, KMT, LNSR, MOG.A, MTX, NPK, NTGR, ORION, PAHC, PKE, RBBN, SMG, TKR, UTMD, WKC | aerospace, healthcare, industrials, Machinery, small caps, technology, value | TKR | Brandes Small Cap Value Fund outperformed significantly in Q4 2024 with a 5.76% return versus 0.33% for Russell 2000, driven by strong industrials exposure including machinery and aerospace companies. The fund maintains its value-oriented approach with lower valuations than the benchmark while focusing on companies with strong balance sheets and durable cash flow generation. |
| QUARTER | THEMES | TAGS |
|---|---|---|
| 2026 Q1 |
AIAI disruption concerns pressured technology holdings including IT services companies and software businesses. The market has reassessed the potential impact of generative AI on traditional IT services models and legacy enterprise software, though the manager believes near-term disruption risks are overstated. |
Artificial Intelligence Disruption Software IT Services Generative AI |
ValueThe fund continues to focus on companies trading at attractive valuations with strong balance sheets and compelling growth prospects. Management believes value stocks offer attractive long-term risk/reward potential and the fund exhibits lower valuations than broader small-cap indices. |
Value Investing Valuations Balance Sheets Margin of Safety | |
Small CapsThe fund outperformed small-cap benchmarks and management remains optimistic about small-cap value opportunities. They view the fund as an attractive complement to other small-cap offerings due to its focus on companies with strong fundamentals and durable free-cash-flow generation. |
Small Cap Russell 2000 Outperformance Free Cash Flow | |
| 2025 Q4 |
AIManager discusses AI monetization progress at Alphabet with Gemini platform enhancements and Google Cloud growth exceeding 30% year-over-year. Focus shifted toward return on invested capital rather than headline growth in technology. CoreWeave positioned in high-performance cloud compute market with purpose-built infrastructure for AI workloads. |
Cloud Computing Infrastructure Monetization Enterprise |
GLP1Eli Lilly delivered strong performance driven by GLP-1 franchises Mounjaro and Zepbound, with sales more than doubling year-over-year. Demand continues to outpace supply with additional indications on the horizon. Manager views this as providing durable competitive advantages and sustained revenue growth over the coming decade. |
Diabetes Obesity Pharmaceuticals Growth | |
StreamingNetflix faced headwinds from concerns around subscriber growth and rising content spending, with slower net additions in North America and Europe after price increases. Proposed Warner Bros. Discovery acquisition introduces regulatory and integration risks. Despite challenges, manager views Netflix as dominant global platform with durable competitive advantages. |
Content Subscribers Competition Consolidation | |
CloudGoogle Cloud grew more than 30% year-over-year supported by rapid adoption of AI training and inference services. CoreWeave's purpose-built infrastructure positioned within high-performance cloud compute market with differentiated architecture and strategic partnerships across semiconductor supply chain. |
Infrastructure Growth Enterprise Computing | |
| 2025 Q3 |
ValueThe fund focuses on small-cap value investing, seeking companies trading below intrinsic value estimates. The manager emphasizes the fund's lower valuations compared to the Russell 2000 Index while offering exposure to companies with strong balance sheets and compelling growth prospects. |
Intrinsic Value Undervalued Balance Sheets Valuations Risk/Reward |
Small CapsThe fund specifically targets small-cap companies across multiple sectors, with particular emphasis on industrials, health care, and consumer discretionary. The manager believes small-cap value stocks remain well positioned from a long-term perspective. |
Russell 2000 Small-Cap Market Sector Allocation Positioning Outperformance | |
AIThe fund invested in Globant, an IT services company specializing in AI and digital engineering services. The manager acknowledges AI-related risks but believes these concerns are overpriced in Globant's current valuation, positioning the company to benefit from AI adoption scaling. |
Digital Transformation Generative AI IT Services Automation Technology | |
| 2025 Q2 |
ValueThe fund focuses on small-cap value investing, seeking companies trading below intrinsic value estimates. The manager emphasizes the fund's lower valuations compared to the Russell 2000 Index while offering exposure to companies with strong balance sheets and compelling growth prospects. |
Intrinsic Value Undervalued Balance Sheets Valuations Risk/Reward |
Small CapsThe fund specifically targets small-cap companies, maintaining significant exposure to industrials sector while being underweight financials and real estate. The manager views the fund as an attractive complement to other small-cap offerings due to its differentiated positioning. |
Russell 2000 Small-Cap Market Sector Allocation Industrials Positioning | |
PharmaceuticalsHealthcare sector holdings led performance, particularly animal health companies Elanco and Phibro, along with Avadel's sleep medication success. The fund added Prestige Consumer Healthcare, an over-the-counter pharmaceutical manufacturer with defensive demand characteristics. |
Animal Health OTC Pharmaceuticals Healthcare Defensive Demand Brand Building | |
| 2025 Q1 |
ValueThe fund focuses on small-cap value investing, seeking companies trading at undemanding valuations below intrinsic value estimates. The manager emphasizes the fund exhibits lower valuations than the Russell 2000 Index while offering exposure to companies with strong balance sheets and compelling growth prospects. |
Intrinsic Value Valuations Balance Sheets Free Cash Flow |
Small CapsThe fund specifically targets small-cap companies, maintaining positions across industrials, healthcare, consumer discretionary, materials, and energy sectors. The manager believes the fund remains well positioned from a long-term risk/reward perspective in the small-cap space. |
Russell 2000 Small Cap Risk Reward Positioning | |
| 2024 Q4 |
ValueThe fund seeks long-term capital appreciation through value investing in small-cap companies. The fund exhibits lower valuations than the Russell 2000 Index while offering exposure to companies with strong balance sheets and compelling growth prospects. The manager believes value stocks have attractive potential going forward. |
Value Undervalued Intrinsic Value Valuations Small Caps |
IndustrialsAllocation to companies in the industrials sector continues to be the largest weighting and relative overweight from a sector standpoint. Leading contributors included machinery companies Graham and L.B. Foster, construction and engineering business Orion Group, and aerospace and defense companies CAE and Park Aerospace. |
Industrials Machinery Construction Aerospace Defense | |
AerospaceThe fund has significant exposure to aerospace and defense companies including CAE, Park Aerospace, Embraer, and Moog. These holdings were among the leading performers, with aerospace and defense companies contributing positively to returns both in the quarter and year-to-date. |
Aerospace Defense Aviation Components Equipment |
| Date | Pitch Type | Author | Ticker | Company | Industry | Sub Industry | Bull / Bear | Exchange | Keywords | Action |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | Fund Letters | Brandes Small Cap Value Fund | MHK | Mohawk Industries Inc | Furnishings, Fixtures & Appliances | Building Products | Bull | New York Stock Exchange | Building Products, capital allocation, Cyclical, Flooring, Free Cash Flow, manufacturing, Scale Advantages, turnaround, Value | Login |
| Mar 31, 2026 | Fund Letters | Brandes Small Cap Value Fund | NICE | NICE Ltd | Software - Application | Application Software | Bull | NASDAQ | AI, CCaaS, Cloud software, Contact center, Israel, SaaS, Technology Disruption, Value, Workforce Management | Login |
| Mar 31, 2026 | Fund Letters | Brandes Small Cap Value Fund | MHK | Mohawk Industries Inc | Furnishings, Fixtures & Appliances | Building Products | Bull | New York Stock Exchange | Building Products, capital allocation, Cyclical, Flooring, Free Cash Flow, manufacturing, Scale Advantages, turnaround, Value | Login |
| Mar 31, 2026 | Fund Letters | Brandes Small Cap Value Fund | NICE | NICE Ltd | Software - Application | Application Software | Bull | NASDAQ | AI, CCaaS, Cloud software, Contact center, Israel, SaaS, Technology Disruption, Value, Workforce Management | Login |
| Jan 23, 2026 | Fund Letters | Bryan Barrett | CENT | Central Garden & Pet Company | Consumer Staples | Household Products | Bull | NASDAQ | Acquisitions, Costreduction, Gardening, Margins, Pets | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | GLOB | Globant S.A. | Information Technology | IT Services | Bull | NYSE | AI, Consulting, Digital transformation, growth, IT services, recovery, valuation | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | PBH | Prestige Consumer Healthcare | Health Care | Pharmaceuticals | Bull | NYSE | Acquisitions, brands, cashflow, consumer, healthcare, OTC, pharmaceuticals | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | GLOB | Globant S.A. | Information Technology | IT Services | Bull | NYSE | AI, Consulting, Digital transformation, growth, IT services, recovery, valuation | Login |
| Oct 21, 2025 | Fund Letters | Bryan Barrett | PBH | Prestige Consumer Healthcare | Health Care | Pharmaceuticals | Bull | NYSE | Acquisitions, brands, cashflow, consumer, healthcare, OTC, pharmaceuticals | Login |
| Sep 30, 2025 | Fund Letters | Brandes Small Cap Value Fund | PBH | Prestige Consumer Healthcare Inc | Health Care | Pharmaceuticals | Bull | NYSE | Brand Builder, Consumer healthcare, defensive, M&A, market leadership, OTC Pharmaceuticals, share repurchases, Value | Login |
| Sep 30, 2025 | Fund Letters | Brandes Small Cap Value Fund | GLOB | Globant SA | Information Technology | IT Services | Bull | NYSE | AI, cloud, Cyclical, Digital transformation, growth, High Margin Services, IT services, Latin America, Value | Login |
| Mar 31, 2025 | Fund Letters | Brandes Small Cap Value Fund | PZZA | Papa John's International Inc | Consumer Discretionary | Restaurants | Bull | NASDAQ | Consumer Discretionary, food delivery, franchise, Pizza, QSR, Restaurants, turnaround, Value | Login |
| Dec 31, 2024 | Fund Letters | Brandes Small Cap Value Fund | TKR | The Timken Company | Industrials | Machinery | Bull | NYSE | aftermarket, Automation, Bearings, Cyclical, dividend, Industrial Motion, Power Transmission, renewables, Share Buybacks, Value | Login |
| TICKER | COMMENTARY |
|---|---|
| KMT | Kennametal significantly raised its guidance for fiscal year 2026 and is expected to be a key beneficiary of the material increase in tungsten prices, providing a potential positive tailwind to its margins. |
| PKE | Park Aerospace benefited from surging demand for its missile defense materials. It also reported strong earnings. |
| IMKTA | Ingles Markets continued to recover from operating challenges during previous years; it announced noteworthy year-over-year profitability growth. |
| EPC | Edgewell completed the sale of its feminine care business for $340 million. The proceeds strengthened its balance sheet, which investors viewed favorably. |
| GLOB | IT services companies Globant and Amdocs declined as investors reassessed the potential impact of generative AI on traditional IT services models, particularly in application development and consulting. |
| DOX | IT services companies Globant and Amdocs declined as investors reassessed the potential impact of generative AI on traditional IT services models, particularly in application development and consulting. |
| OTEX | Software company Open Text also detracted from performance. Investor concerns centered on the durability of legacy enterprise software models amid rapid advances in AI-enabled information management tools. While Open Text continued to generate substantial recurring revenue from its mission-critical software, uncertainty regarding integration execution and AI-related disruption weighed on sentiment. In our view, the market has overstated near-term disruption risks, while discounting the strength of Open Text's installed base and customer switching costs, causing the company's shares to trade at what we consider appealing valuations. |
| LNSR | In March, Lensar and Alcon announced they were abandoning Alcon's proposed acquisition of Lensar after the FTC moved to block the transaction on antitrust grounds. |
| MHK | Mohawk Industries is the world's largest flooring manufacturer. With a leading position on ceramic tile, carpet, laminate, vinyl and stone products, the company serves residential remodeling, new construction and commercial markets. Its global manufacturing and distribution footprint provides substantial scale advantages, broad product reach and cost efficiency across cycles. The market is currently focused on near-term headwinds facing Mohawk, including slowing home-remodeling demand, elevated input costs and margin pressure after an unusually strong post-COVID rebound. While cycle risks are still elevated, the company benefits, in our opinion, from a strong balance sheet and a free-cash-flow profile that has stayed positive throughout this period. Additionally, management owns a meaningful equity stake and has shown a willingness to deploy capital opportunistically through share repurchases and acquisitions during times of industry stress. In our view, Mohawk trades at a valuation that can withstand a prolonged downturn scenario. Based on our assessment of normalized earnings power and balance sheet strength, we believe its shares offer an attractive margin of safety and favorable long-term return potential. |
| NICE | NICE Ltd. is a Contact Center-as-a-Service (CCaaS) provider, maintaining dual headquarters in Israel and the United States, with a customer base that is predominantly in the U.S. NICE has evolved alongside changing technology and customer requirements. However, in 2025 rapid advances in AI capability and adoption began to cloud NICE's outlook. On one hand, improving AI functionality has accelerated the shift toward CCaaS solutions and away from on-premise deployments. On the other, the pace of change has intensified competition among CCaaS providers and has driven increased investment to incorporate advanced AI features. NICE has indicated that this heightened investment, including the approximately $1-billion acquisition of Cognigy, will put pressure on its earnings over the next year. This uncertainty contributed to a sharp correction in the share price, pushing it to multi-year lows and compressing valuation multiples to near all-time lows. While it is impossible to predict definitive winners and losers in the AI arms race, NICE remains favorably positioned as an established incumbent in the CCaaS market with a well-capitalized balance sheet. AI-enhanced contact center functionality could meaningfully expand the overall market size over time. We will continue to monitor the competitive landscape for evidence of NICE's performance in navigating this transition. For the patient, long-term investor, the current opportunity in NICE appears attractive. |
| Ticker | Put/Call | Amount Bought | Shares Bought | % Change | Weight % |
|---|---|---|---|---|---|
| No Recent Buys Data | |||||
| Ticker | Put/Call | Amount Sold | Shares Sold | % Change | Weight % | Status |
|---|---|---|---|---|---|---|
| No Recent Sells Data | ||||||
| Industry | Prev Quarter % | Current Quarter % | Change |
|---|---|---|---|
| No industry data available | |||